Skip to main content
Data in Brief logoLink to Data in Brief
. 2019 Jun 1;25:104087. doi: 10.1016/j.dib.2019.104087

The components data of fuzheng huayu extracts, cordyceps sinensis mycelia polysaccharide, gypenosides and amygdalin

Wei Liu a, Zhixiong Li c, Zhaolin Sun c, Yongbin Xu f, Shunchun Wang f, Yiyang Hu b,d,e, Jinghua Peng a,d,e,
PMCID: PMC6595274  PMID: 31294053

Abstract

Fuzheng Huayu (FZHY) capsule is a traditional Chinese medicine composed of six Chinese medicinal herbs Tian et al. [1] and approved by China food and drug administration for liver fibrosis treatment [2], [3] Liu et al., 2009 and Liu et al., 2005. CGA formula consisting of Cordyeps sinensis polysaccharide (CS-PS), gypenosides (G), and amygdalin (A), are derived from FZHY formula. It is necessary to identify the chemical profile of FZHY and CGA formula to describe the mechanisms and the corresponding components of anti-fibrosis. It is showed that FZHY contains adenosine (5.21 mg/g), amygdalin (5.31 mg/g), salvianolic acid b (18.22 mg/g) and deoxyschizandrin (2.62 mg/g), respectively. CS-PS contained 60.5 ± 2.2% total carbohydrate, including 14.17% arabinose, 25.35% glucose and 60.48% galactose. Gypenosides contain 10.34% gypenosides XLIX and 16.58% gypenosides A. These data provide the primary chemical profile of FZHY and CGA formula and an example for components analysis of traditional Chinese medicine.

Keywords: High-performance liquid chromatography, Traditional Chinese medicine, Fuzheng huayu capsule, Cordyeps sinensis polysaccharide, Gypenosides


Specifications table

Subject area Chemistry
More specific subject area Chemical analysis of phytomedicine
Type of data Tables and figures
How data was acquired Gypenosides was analyzed with high-pressure liquid chromatography (Agilent 1200 Series, USA). Total carbohydrate content of CS-PS was determined by the phenol-sulphuric acid method. The carbohydrate composition of CS-PS was analyzed by gas chromatograph-mass spectrometer (Thermo Fisher Scientific Inc., FL, USA). The components of FZHY extract was analyzed by using ultra-high-performance liquid chromatography-Q exactive hybrid quadrupole orbitrap high-resolution accurate mass spectrometric (UHPLC-Q-Orbitrap HRMS, Thermo Fisher Scientific Inc., Grand Island, NY, USA).
Data format Raw
Experimental factors Before mass spectroscopy, FZHY extracts and gypenosides were dissolved by methanol. CS-PS was hydrolyzed by trifluoroacetic acid, then was vacuum dried and dissolved in methanol.
Experimental features Samples were prepared and analyzed according to the protocol described previously[1], [4], [5].
Data source location Shanghai, China
Data accessibility Data is with this article
Related research article Huajie Tian, Lin Liu, Zhixiong Li, Wei Liu, Zhaolin Sun, Yongbin Xu, Shunchun Wang, Chungeng Liang, Yamei Hai, Qin Feng, Yu Zhao, Yiyang Hu, Jinghua Peng. Chinese medicine CGA formula ameliorates liver fibrosis induced by carbon tetrachloride involving inhibition of hepatic apoptosis in rats. Journal of ethnopharmacology 2019; 232: 227–35. DOI:10.1016/j.jep.2018.11.027[1].
Value of the data
  • People can find and cite the components of Fuzheng Huayu (FZHY) capsule which is approved by China food and drug administration for treatment of liver fibrosis.

  • The data provides reference of the carbohydrate content and components of Cordyeps sinensis polysaccharide (CS-PS).

  • People can find and reference the components of Herba Gynostemmae gypenosides.

  • People can find and cite the chemical components of CGA formula, which is derived from FZHY and has been reported in several research articles.

1. Data

The data presented here provided the primary chemical profile of FZHY (formula shown in Table 1) and CGA formula. In FZHY, the contents of adenosine, amygdalin, salvianolic acid b and deoxyschizandrin extracts were determined as 5.21 mg/g, 5.31 mg/g, 18.22 mg/g and 2.62 mg/g respectively (Fig. 1). In CGA formula, the molecular structure of amygdalin (Fig. 2) and the chemical profile of cordyeps sinensis polysaccharide and gypenosides were determined. The total carbohydrate content of cordyeps sinensis polysaccharide was determined as 60.5 ± 2.2% (Fig. 3). The carbohydrate composition analysis showed cordyeps sinensis polysaccharide contained 14.17% arabinose, 25.35% glucose and 60.48% galactose (Fig. 4). Gypenosides contained 10.34% gypenosides XLIX and 16.58% gypenosides A (Fig. 5).

Table 1.

The formula of FZHY.

Pharmaceutical name Botanical name Family and plant part use Chinese name % (w/w)
Salviae Miltiorrhizae Radix et Rhizoma Salvia miltiorrhiza Bunge Lamiaceae; radix; Danshen 33.3
Artificial fermentation cordyceps Cordyceps sinensis (BerK.) Sacc. Clavicipitaceae; mycelia Chongcao 16.7
Persicae Semen Prunus persica (L.) Batsch Rosaceae; seed Taoren 8.3
*Herba Gynostemmae Gynostemma pentaphyllum (Thunb.) Makino Cucurbitaceae; whole herb Jiaogulan 25
Pini Pollen Pinus massoniana Lamb. Pinaceae; pollen Songhuafen 8.3
Schisandrae Chinensis Fructus Schisandra chinensis (Turcz.) Baill. Schisandraceae; fruit Wuweizi 8.3

*The botanical name of Jiaogulan is from The Drug Standard of Gugangxi Province (1996 Edition), the others are from The Pharmacopoeia of the People's Republic of China (2015 Edition). The botanical names have been updated with www.theplantlist.org.

Fig. 1.

Fig. 1

The typical LC-MS fingerprint chromatograms of extract of FZHY (A) and mixture reference standards (B). TIC, Total-ion chromatograms, 1, Adenosine, 2, amygdalin, 3, salvianolic acid b, 4, deoxyschizandrin. The contents of adenosine, amygdalin, salvianolic acid b and deoxyschizandrin in FZHY extract were determined as 5.21 mg/g, 5.31 mg/g, 18.22 mg/g and 2.62 mg/g, respectively.

Fig. 2.

Fig. 2

Chemical structure of Amygdalin.

Fig. 3.

Fig. 3

Standard curve of total carbohydrate content determined by phenol-sulfuric acid method. A490 nm, the absorbance of standard samples on 490 nm, Glc μg/ml, the content of glucose.

Fig. 4.

Fig. 4

Chemical components of CS-PS (bottom image) and standard (above image, ribose, arabinose, xylose, mannose, glucose, galactose) analyzed by gas chromatograph-mass spectrometer (GC-MS) (TRACE-DSQ, Thermo Fisher Scientific Inc., FL, USA). Above image, standard analysis showed that CS-PS contained 14.17% arabinose, 25.35% glucose and 60.48% galactose.

Fig. 5.

Fig. 5

HPLC chromatograms of gypenosides and the standard compounds. (A), gypenoside XLIX, (B), gypenosides A, (C), gypenosides Gypenosides contained 10.34% gypenosides XLIX and 16.58% gypenosides A.

2. Experimental design, materials and methods

2.1. Materials

The formula of FZHY [2], [3] was presented in Table 1. The FZHY extracts (batch number: 180206) were prepared and provided by Shanghai Sundise Medicine Technology Development Co., Ltd. (Shanghai, China). Cordyeps sinensis polysaccharide (CS-PS, purity 62.6%), Herba Gynostemmae gypenosides (purity 92.8%) and amygdalin ([(6-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy](phenyl)acetonitrile) (Fig. 2, purity 98%) were prepared and provided by Shanghai Institute of Materia Medica, Chinese Academy of Sciences (Shanghai, China).

2.2. Methods

FZHY extracts were analyzed by ultra-high-performance liquid chromatography-Q exactive hybrid quadrupole orbitrap high-resolution accurate mass spectrometric (UHPLC-Q-Orbitrap HRMS, Thermo Fisher Scientific Inc., Grand Island, NY, USA) [1] and standards of the components in FZHY identified previously [6], [7], [8], [9]. FZHY extracts contain adenosine (5.21 mg/g), amygdalin (5.31 mg/g), salvianolic acid b (18.22 mg/g) and deoxyschizandrin (2.62 mg/g) (Fig. 1).

Phenol-sulfuric acid method (Table 2) was employed to determin the total carbohydrate content of CS-PS [4], [5]. The total carbohydrate content of CS-PS was 60.5 ± 2.2% based on the calibration curve (Fig. 3). The carbohydrate composition of CS-PS was analyzed by gas chromatograph-mass spectrometer (GC-MS) (Thermo Fisher Scientific Inc, Waltham, MA, USA) [4], [5], including 14.17% arabinose, 25.35% glucose and 60.48% galactose (Fig. 4).

Table 2.

The procedure of reagents admixture in phenol-sulfuric acid method.

Reagents Standard 1 (ml) Standard 2 (ml) Standard 3 (ml) Standard 4 (ml) Standard 5 (ml) Standard 6 (ml) Standard 7 (ml) CS-PS sample (ml)
48μg/ml glucose 0 0.4 0.7 1.0 1.3 1.6 2 0
deionized water 2 1.6 1.3 1.0 0.7 0.4 0 0
CS-PS sample solution 0 0 0 0 0 0 0 2
6% phenol 1 1 1 1 1 1 1 1
sulfuric acid 5 5 5 5 5 5 5 5

Standard: 0–48μg/ml glucose (Sigma, MO, USA), CS-PS sample solution: CS-PS (25 mg) was dissolved in 250mL of deionized water and centrifuged at 1000 g for 10 min. The CS-PS solution (2 mL) was added into the testing tube for detection.

The gypenosides were analyzed by high-performance liquid chromatography (HPLC) (Agilent 1200 Series, Santa Clara, CA, USA) [4], [5]. The gypenosides contain 10.34% gypenosides XLIX and 16.58% gypenosides A (Fig. 5).

Acknowledgements

This work was supported by National Science and Technology Major Project of China (2012ZX09103-201-048); National Natural Science Foundation of China (No. 81303071); Shanghai Science and Technology Committee (17PJ1408900).

Contributor Information

Wei Liu, Email: lwhzayl@163.com.

Zhixiong Li, Email: zxli0715@126.com.

Zhaolin Sun, Email: iamszl0924@163.com.

Yongbin Xu, Email: XYBpharmacy@163.com.

Shunchun Wang, Email: shunchunwang@126.com.

Yiyang Hu, Email: yyhuliver@163.com.

Jinghua Peng, Email: pengjinghua2004@163.com.

Conflict of Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

  • 1.Tian H., Liu L., Li Z., Liu W., Sun Z., Xu Y. Chinese medicine CGA formula ameliorates liver fibrosis induced by carbon tetrachloride involving inhibition of hepatic apoptosis in rats. J. Ethnopharmacol. 2019;232:227–235. doi: 10.1016/j.jep.2018.11.027. [DOI] [PubMed] [Google Scholar]
  • 2.Liu C., Hu Y., Xu L., Liu C., Liu P. Effect of Fuzheng Huayu formula and its actions against liver fibrosis. Chin. Med. 2009;4:12. doi: 10.1186/1749-8546-4-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Liu P., Hu Y.Y., Liu C., Xu L.M., Liu C.H., Sun K.W. Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B. World J. Gastroenterol. 2005;11(19):2892–2899. doi: 10.3748/wjg.v11.i19.2892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Peng J., Li X., Feng Q., Chen L., Xu L., Hu Y. Anti-fibrotic effect of Cordyceps sinensis polysaccharide: inhibiting HSC activation, TGF-beta1/Smad signalling, MMPs and TIMPs. Exp. Biol. Med. 2013;238(6):668–677. doi: 10.1177/1535370213480741. [DOI] [PubMed] [Google Scholar]
  • 5.Saha S.K., Brewer C.F. Determination of the concentrations of oligosaccharides, complex type carbohydrates, and glycoproteins using the phenol-sulfuric acid method. Carbohydr. Res. 1994;254:157–167. doi: 10.1016/0008-6215(94)84249-3. [DOI] [PubMed] [Google Scholar]
  • 6.Peng Y., Huang K., Shen L., Tao Y.Y., Liu C.H. Cultured Mycelium Cordyceps sinensis allevi notates CCl4-induced liver inflammation and fibrosis in mice by activating hepatic natural killer cells. Acta Pharmacol. Sin. 2016;37(2):204–216. doi: 10.1038/aps.2015.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Yang T., Liu S., Wang C.H., Tao Y.Y., Zhou H., Liu C.H. Comparative pharmacokinetic and tissue distribution profiles of four major bioactive components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe. J. Pharm. Biomed. Anal. 2015;114:152–158. doi: 10.1016/j.jpba.2015.05.014. [DOI] [PubMed] [Google Scholar]
  • 8.Yang T., Shen D.P., Wang Q.L., Tao Y.Y., Liu C.H. Investigation of the absorbed and metabolized components of Danshen from Fuzheng Huayu recipe and study on the anti-hepatic fibrosis effects of these components. J. Ethnopharmacol. 2013;148(2):691–700. doi: 10.1016/j.jep.2013.05.031. [DOI] [PubMed] [Google Scholar]
  • 9.Yang T., Liu S., Zheng T.H., Tao Y.Y., Liu C.H. Comparative pharmacokinetics and tissue distribution profiles of lignan components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe. J. Ethnopharmacol. 2015;166:305–312. doi: 10.1016/j.jep.2015.03.024. [DOI] [PubMed] [Google Scholar]

Articles from Data in Brief are provided here courtesy of Elsevier

RESOURCES